News, Articles & Resources
Cancer Research and Cancer Support Articles
Discover how low-dose radiation therapy offers a non-surgical option for chronic plantar fasciitis that hasn’t improved with conservative care.
FDA approves KEYTRUDA for certain hard-to-treat ovarian cancers, with research support from FCS improving outcomes.
FCS joins oncology leaders at FLASCO 2026 to share insights on workforce transformation and innovative care models shaping the future of cancer care.
FCS contributes to PRESERVE-003 findings showing gotistobart may improve outcomes in metastatic NSCLC.
FCS participates in study for a targeted therapy for the treatment of two cancers
Florida Cancer Specialists & Research Institute welcomes Nikita Jain, MD, to the team.
Learn what benign conditions are, including noncancerous growths and inflammatory changes, how they differ from cancer, and when monitoring or treatment may be needed.
Florida Cancer Specialists & Research Institute welcomes Xin Yao, MD to Collier County.
FCS Top News Updates
August 10, 2026
FCS Welcomes Neel K. Gakhar, MD
August 4, 2026
FCS Expands Martin County Team with Elizabeth Blowers, MD, PhD
August 3, 2026
FCS Welcomes Nagapratap Ganta, MD and Aryanna Jordan, MD to Statewide Practice
July 29, 2026
FCS Physician Executive Examines Leadership Strategies Shaping the Future of Cancer Care in Published Article
Radiation Therapy for Plantar FasciitisDiscover how low-dose radiation therapy offers a non-surgical option for chronic plantar fasciitis that hasn’t improved with conservative care.
FCS Contributes to Milestone that Expands Treatment Options For Patients With Recurrent Ovarian CancerFDA approves KEYTRUDA for certain hard-to-treat ovarian cancers, with research support from FCS improving outcomes.
FCS Joins Oncology Leaders to Help Shape the Future of Cancer Care at FLASCO 2026FCS joins oncology leaders at FLASCO 2026 to share insights on workforce transformation and innovative care models shaping the future of cancer care.
FCS Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung CancerFCS contributes to PRESERVE-003 findings showing gotistobart may improve outcomes in metastatic NSCLC.
FCS Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung and Pancreatic CancersFCS participates in study for a targeted therapy for the treatment of two cancers
FCS Welcomes Nikita Jain, MD to PracticeFlorida Cancer Specialists & Research Institute welcomes Nikita Jain, MD, to the team.
Benign Conditions – Summary, Symptoms, TreatmentsLearn what benign conditions are, including noncancerous growths and inflammatory changes, how they differ from cancer, and when monitoring or treatment may be needed.
FCS Expands Team of Cancer Experts in Lee CountyFlorida Cancer Specialists & Research Institute welcomes Xin Yao, MD to Collier County.